Related Experiment Video
Updated: Jul 6, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
[Anaphylactoid purpura after intravesical therapy using bacillus Calmette-Guerin for superficial bladder cancer]
Takahiro Hirayama1, Kazumasa Matsumoto, Toshiki Tsuboi
1The Department of Urology, Kitasato University School of Medicine.
Abstract:
We report a very rare side effect, anaphylactoid purpula, after intravesical administration of bacillus Calmette-Guerin (BCG). A 83-year-old man presented with purpura located on his bilateral lower legs. He had received transurethral resections four times for superficial bladder tumors. Intravesical therapy using BCG was performed. During the treatment course, asymptomatic purpura was suddenly seen in the lower legs after the third administration. Lymphocyte stimulation test was highly positive for BCG. He was diagnosed with anaphylactoid purpura caused by BCG. Conservative treatment was selected because there were no concomitant diseases in other organs. There have been no signs of recurrence of tumors or purpura during the one-year follow-up. However, physicians need to be cautious of anaphylactoid purpura which could lead to severe diseases, such as renal failure, gastrointestinal dysfunction and systematic arthritis.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Imaging Studies VI: Voiding Cystourethrography and Cystography